PDT will have a Cynvenio Liquid Biopsy instrument, an automated system designed for the recovery and characterization of circulating tumor cells (CTC) from blood, in their booth and available for demonstration. PDT’s team of designers and engineers worked through many unique challenges to help Cynvenio Biosystems bring this revolutionary technology to market. Read more about the development of this solution here: http://www.mdtmag.com/articles/2014/07/molecular-revolution-development-breakthrough-cancer-treatment
PDT’s CEO, Mark Schwartz, will be holding an informal session at Booth 4069 about “Leveraging Mobile Technology in Laboratory and Clinical Devices” on Tuesday, July 28 at 4:00pm. To see his presentation, simply stop by PDT’s booth at that time.
Join us at